eMedicine Specialties > Emergency Medicine > Cardiovascular

Tetralogy of Fallot

Author: Mark Spektor, DO, Medical Director, Department of Emergency Medicine, Maimonides Medical Center
Coauthor(s): David A Donson, MD, Assistant Medical Director, Department of Emergency Medicine, Maimonides Medical Center; Kurt Pflieger, MD, FAAP, Active Staff, Department of Pediatrics, Lake Pointe Medical Center
Contributor Information and Disclosures

Updated: Dec 22, 2008

Introduction

Background

Tetralogy of Fallot (TOF) is a complex of anatomic abnormalities arising from the maldevelopment of the right ventricular infundibulum.

In 1888, Fallot described the anatomy as consisting of pulmonary artery stenosis, ventricular septal defect (VSD), deviation of the aortic origin to the right, and right ventricular hypertrophy. Today, it is apparent that it is the degree of right ventricular outflow tract (RVOT) obstruction (infundibular stenosis) that accounts for the deleterious hemodynamics of TOF. See Media file 1 for a schematic illustration of these abnormalities.

Anatomic findings in tetralogy of Fallot.

Anatomic findings in tetralogy of Fallot.

Anatomic findings in tetralogy of Fallot.

Anatomic findings in tetralogy of Fallot.


Pathophysiology

Wide variation exists in the basic anatomic morphology, pathophysiology, clinical signs and symptoms, and surgical methods of therapy for TOF. Pathophysiology is dependent primarily upon severity of the right ventricular outflow tract (RVOT) obstruction. RVOT obstruction determines the severity of right-to-left shunting, which is typical.

Frequency

United States

TOF represents approximately 10% of cases of congenital heart disease and is the most common cause of cyanotic congenital heart disease.

Mortality/Morbidity

Natural history is variable.

  • Natural history is determined mainly by the degree of RVOT obstruction.
  • Approximately 25% of untreated patients with TOF and RVOT obstruction die within the first year of life, 40% by 4 years, 70% by 10 years, and 95% by 40 years. However, cases of survival of patients into their 80s have been reported.

Sex

Incidence of tetralogy of Fallot (TOF) is slightly higher in males than in females.

Age

TOF occurs in newborns.

Clinical

History

  • Cyanosis may be present at or shortly after birth but usually develops within the first few years of life.
  • First presentation may include poor feeding, cyanosis during feeding, fussiness, tachypnea, and agitation.
  • Symptoms generally progress secondary to hypertrophy of the infundibular septum. Worsening of the RVOT obstruction leads to right ventricular hypertrophy, increased right-to-left shunting, and systemic hypoxemia.
  • Cyanosis generally progresses with age and outgrowth of pulmonary vasculature and demands surgical repair.
  • Dyspnea on exertion is common.
  • Squatting (a compensatory mechanism) is uniquely characteristic of a right-to-left shunt that presents in the exercising child. Squatting increases the peripheral vascular resistance, which diminishes the right-to-left shunt and increases pulmonary blood flow.
  • Hypoxic "tet" spells are potentially lethal, unpredictable episodes that occur even in noncyanotic patients with TOF. The mechanism is thought to include spasm of the infundibular septum, which acutely worsens the RVOT obstruction. These spells can be aborted with relatively simple procedures.
  • The rare patient may remain marginally and imperceptibly cyanotic, or acyanotic and asymptomatic, into adult life.
  • Severe cyanosis may present at birth in a patient with TOF and associated pulmonary atresia.
  • Birth weight is low.
  • Growth is retarded.
  • Development and puberty may be delayed.

Physical

  • Right ventricular predominance on palpation
  • May have a bulging left hemithorax
  • Systolic thrill at the lower left sternal border
  • Aortic ejection click
  • Single S 2 - Pulmonic valve closure not heard
  • Systolic ejection murmur - Varies in intensity inversely with the degree of RVOT obstruction
    • More cyanotic patients have greater obstruction and a softer murmur.
    • An acyanotic patient with TOF (pink tet) has a long, loud, systolic murmur with a thrill along the RVOT.
  • Cyanosis and clubbing - Variable
  • Squatting position
  • Scoliosis - Common
  • Retinal engorgement
  • Hemoptysis

Causes

  • As one of the conotruncal malformations, tetralogy of Fallot (TOF) can be associated with a spectrum of lesions known as CATCH 22 (cardiac defects, abnormal facies, thymic hypoplasia, cleft palate, hypocalcemia). Cytogenetic analysis may demonstrate deletions of a segment of chromosome band 22q11 (DiGeorge critical region).
  • Ablation of cells of the neural crest has been shown to reproduce conotruncal malformations.
  • These abnormalities are associated with the DiGeorge syndrome and branchial arch abnormalities.
  • TOF may be associated with maternal stressful life events during pregnancy.
  • TOF frequently is associated with the following:
    • Fetal hydantoin syndrome
    • Fetal carbamazepine syndrome
    • Fetal alcohol syndrome
    • Maternal phenylketonuria (PKU) birth defects

More on Tetralogy of Fallot

Overview: Tetralogy of Fallot
Differential Diagnoses & Workup: Tetralogy of Fallot
Treatment & Medication: Tetralogy of Fallot
Follow-up: Tetralogy of Fallot
Multimedia: Tetralogy of Fallot
References

References

  1. Senzaki H, Ishido H, Iwamoto Y, et al. Sedation of hypercyanotic spells in a neonate with tetralogy of Fallot using dexmedetomidine. J Pediatr (Rio J). Jul-Aug 2008;84(4):377-80. [Medline].

  2. Kantorova A, Zbieranek K, Sauer H, et al. Primary early correction of tetralogy of Fallot irrespective of age. Cardiol Young. Apr 2008;18(2):153-7. [Medline].

  3. Miatton M, De Wolf D, François K, et al. Intellectual, neuropsychological, and behavioral functioning in children with tetralogy of Fallot. J Thorac Cardiovasc Surg. Feb 2007;133(2):449-55. [Medline].

  4. Aboulhosn J, Child JS. Management after childhood repair of tetralogy of fallot. Curr Treat Options Cardiovasc Med. Dec 2006;8(6):474-83. [Medline].

  5. Anderson RH, Weinberg PM. The clinical anatomy of tetralogy of fallot. Cardiol Young. Feb 2005;15 Suppl 1:38-47. [Medline].

  6. Balaji S. Medical therapy for sudden death. Pediatr Clin North Am. Oct 2004;51(5):1379-87. [Medline].

  7. Goldmuntz E. The genetic contribution to congenital heart disease. Pediatr Clin North Am. Dec 2004;51(6):1721-37, x. [Medline].

  8. He GW. Current Strategy of Repair of Tetralogy of Fallot in Children and Adults: Emphasis on a New Technique to Create a Monocusp-Patch for Reconstruction of the Right Ventricular Outflow Tract. J Card Surg. Sep 5 2008;[Medline].

  9. Hövels-Gürich HH, Konrad K, Skorzenski D, et al. Long-term behavior and quality of life after corrective cardiac surgery in infancy for tetralogy of Fallot or ventricular septal defect. Pediatr Cardiol. Sep-Oct 2007;28(5):346-54. [Medline].

  10. Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. Jan 22 2008;117(3):363-70. [Medline].

  11. Kirklin JW, Barrett-Boyes BGF. Ventricular septal defect and pulmonary stenosis or atresia. Cardiac Surgery. 1993;2:861-1012.

  12. Nadas AS. Tetralogy of fallot. In: Nadas Pediatric Cardiology. Hanley & Belfus; 1992:471-93.

  13. Park MK. Tetralogy of fallot. In: Pediatric Cardiology for Practitioners. 3rd ed. Mosby-Year Book; 1996:168-75.

  14. Silverman NH. Tetralogy of fallot and related lesions. In: Pediatric Echocardiography. Lippincott Williams & Wilkins; 1992:195-214.

  15. Snider AR, Serwer GA. Defects in cardiac septation. In: Echocardiography in Pediatric Heart Disease. Mosby-Year Book; 1990:150-3.

  16. Tanel RE. ECGs in the ED. Pediatr Emerg Care. Jun 2007;23(6):428-9. [Medline].

  17. Woods WA, Schutte DA, McCulloch MA. Care of children who have had surgery for congenital heart disease. Am J Emerg Med. Jul 2003;21(4):318-27. [Medline].

  18. Zuberhuler JH. Tetralogy of Fallot. In: Heart Disease in Infants, Children and Adolescents. 2nd ed. 1995:998-1026.

Further Reading

Keywords

tetralogy of Fallot, TOF, Fallot tetrad, Fallot's tetrad, right ventricular outflow tract obstruction, congenital heart disease, maldevelopment of right ventricular infundibulum, subaortic ventricular septal defect, right ventricular infundibular stenosis, aortic valve positioned to override the right ventricle, right ventricular hypertrophy, right-to-leftshunting, cyanosis, hypertrophy of the infundibular septum, dyspnea, retarded growth, aortic ejection click, systolic thrill, systolic ejection murmur, clubbing, scoliosis, squatting position, retinal engorgement, hemoptysis, conotruncal abnormalities, DiGeorge syndrome, branchial arch abnormalities, fetal hydantoin syndrome, fetal carbamazepine syndrome, fetal alcohol syndrome, maternal phenylketonuria birth defects

Contributor Information and Disclosures

Author

Mark Spektor, DO, Medical Director, Department of Emergency Medicine, Maimonides Medical Center
Mark Spektor, DO is a member of the following medical societies: American College of Emergency Physicians, American College of Physician Executives, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

David A Donson, MD, Assistant Medical Director, Department of Emergency Medicine, Maimonides Medical Center
David A Donson, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Kurt Pflieger, MD, FAAP, Active Staff, Department of Pediatrics, Lake Pointe Medical Center
Kurt Pflieger, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Emergency Physicians, American Heart Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Theodore J Gaeta, DO, MPH, FACEP, Clinical Associate Professor, Department of Emergency Medicine, Joan and Sanford Weill Medical College at Cornell University; Vice Chairman and Program Director of Emergency Medicine Residency Program, Department of Emergency Medicine, New York Methodist Hospital; Academic Chair, Adjunct Professor, Department of Emergency Medicine, St George's University School of Medicine
Theodore J Gaeta, DO, MPH, FACEP is a member of the following medical societies: American College of Emergency Physicians, Council of Emergency Medicine Residency Directors, New York Academy of Medicine, New York Academy of Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Gary Setnik, MD, Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School
Gary Setnik, MD is a member of the following medical societies: American College of Emergency Physicians and National Association of EMS Physicians
Disclosure: Intellicare Salary Management position; South Middlesex EMS Consortium Salary Management position

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

David FM Brown, MD, Assistant Professor, Department of Medicine, Division of Emergency Medicine, Harvard Medical School; Associate-Chief, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital
David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Schering  Honoraria Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.